Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots

Intermittent androgen deprivation therapy (IADT) is now being increasingly opted by the treating physicians and patients with prostate cancer. The most common reason driving this is the availability of an off-treatment period to the patients that provides some relief from treatment-related side-effe...

Descripción completa

Detalles Bibliográficos
Autor principal: Abrahamsson, Per-Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772839/
https://www.ncbi.nlm.nih.gov/pubmed/29387553
http://dx.doi.org/10.1016/j.ajur.2017.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772839/
https://www.ncbi.nlm.nih.gov/pubmed/29387553
http://dx.doi.org/10.1016/j.ajur.2017.04.001

Ejemplares similares